These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 32383079

  • 1. The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date.
    Kattoor AJ, Kolkailah AA, Iskander F, Iskander M, Diep L, Khan R, Doukky R.
    J Nucl Cardiol; 2021 Dec; 28(6):2799-2807. PubMed ID: 32383079
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
    Iskander F, Iskander M, Gomez J, Doukky R.
    J Nucl Cardiol; 2021 Jun; 28(3):967-977. PubMed ID: 31144225
    [Abstract] [Full Text] [Related]

  • 3. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.
    Khan MS, Arif AW, Doukky R.
    J Nucl Cardiol; 2022 Apr; 29(2):810-821. PubMed ID: 33034037
    [Abstract] [Full Text] [Related]

  • 4. The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date.
    Kolkailah AA, Iskander M, Iskander F, Patel PP, Khan R, Doukky R.
    J Nucl Cardiol; 2022 Feb; 29(1):101-110. PubMed ID: 32632913
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.
    Lester D, El-Hajj S, Farag AA, Bhambhvani P, Tauxe L, Heo J, Iskandrian AE, Hage FG.
    J Nucl Cardiol; 2016 Oct; 23(5):1147-1155. PubMed ID: 26490267
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging.
    Doukky R, Nigatu A, Khan R, Anokwute C, Fughhi I, Ayoub A, Iskander F, Iskander M, Kola S, Sahyouni M, Karavolos K, Hota BN, Gomez J.
    J Nucl Cardiol; 2020 Oct; 27(5):1521-1532. PubMed ID: 30132187
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of absent left ventricular ejection fraction reserve with regadenoson SPECT MPI.
    Smith P, Farag A, Bhambhvani P, Iskandrian A, Hage FG.
    J Nucl Cardiol; 2022 Jun; 29(3):978-986. PubMed ID: 33089878
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging.
    Kassab K, Hussain K, Torres A, Iskander F, Iskander M, Khan R, Doukky R.
    J Nucl Cardiol; 2022 Apr; 29(2):826-835. PubMed ID: 33034835
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A.
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM, Hage FG, Ahmed A, Dean PJ, Raslan S, Heo J, Iskandrian AE.
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [Abstract] [Full Text] [Related]

  • 11. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.
    Gomez J, Golzar Y, Fughhi I, Olusanya A, Doukky R.
    J Nucl Cardiol; 2018 Aug; 25(4):1313-1323. PubMed ID: 28181156
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging.
    Doukky R, Olusanya A, Vashistha R, Saini A, Fughhi I, Mansour K, Nigatu A, Confer K, Sims SA.
    J Nucl Cardiol; 2015 Aug; 22(4):700-13. PubMed ID: 25907352
    [Abstract] [Full Text] [Related]

  • 13. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S, Ahlberg AW, Rai M, Perucki WH, Felpel KD, Savino JA, Alter EL, Henzlova MJ, Duvall WL.
    J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834
    [Abstract] [Full Text] [Related]

  • 14. A randomized, multicenter, multivendor study of myocardial perfusion imaging with regadenoson CT perfusion vs single photon emission CT.
    Cury RC, Kitt TM, Feaheny K, Blankstein R, Ghoshhajra BB, Budoff MJ, Leipsic J, Min JK, Akin J, George RT.
    J Cardiovasc Comput Tomogr; 2015 Dec; 9(2):103-12.e1-2. PubMed ID: 25726411
    [Abstract] [Full Text] [Related]

  • 15. Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Gomez J, Fughhi I, Campagnoli T, Ali A, Doukky R.
    J Nucl Cardiol; 2017 Oct; 24(5):1666-1671. PubMed ID: 27251142
    [Abstract] [Full Text] [Related]

  • 16. Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging.
    Doukky R, Hayes K, Frogge N, Balakrishnan G, Dontaraju VS, Rangel MO, Golzar Y, Garcia-Sayan E, Hendel RC.
    Circulation; 2013 Oct 08; 128(15):1634-43. PubMed ID: 24021779
    [Abstract] [Full Text] [Related]

  • 17. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Hendel RC, Moye LA, Olmsted AW.
    JACC Cardiovasc Imaging; 2009 Aug 08; 2(8):959-68. PubMed ID: 19679284
    [Abstract] [Full Text] [Related]

  • 18. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
    El-Hajj S, AlJaroudi WA, Farag A, Bleich S, Manaoragada P, Iskandrian AE, Hage FG.
    J Nucl Cardiol; 2016 Feb 08; 23(1):101-12. PubMed ID: 26017713
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
    AlJaroudi W, Campagnoli T, Fughhi I, Wassouf M, Ali A, Doukky R.
    J Nucl Cardiol; 2016 Jun 08; 23(3):560-9. PubMed ID: 26293358
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.